We carried out a systematic review and meta-analysis to assess the safety and effectiveness of uterine artery embolization (UAE) compared with conventional hysterectomy on refractory postpartum hemorrhage (PPH). We searched PubMed, Embase, Chinese National Knowledge Infrastructure database (CNKI), Cochrane Library, and Wanfang database through October 2017 for randomized controlled trials (RCTs) and observational studies assessing the safety and effectiveness of UAE compared with hysterectomy on refractory PPH. The main outcome measures included the blood loss, operating time, hemostatic effective rate, and length of stay. Six RCTs and nine observational studies were included in the meta-analysis, which involved 1142 women with refractory PPH. The results demonstrated that UAE was more beneficial on refractory PPH compared with hysterectomy using four scales: blood loss (WMD 893.39 mL; 95% CI: -1205.65, -581.13; < .001); operating time (WMD -37.19 minutes; 95% CI: -44.42, -29.96; < .001); length of stay (WMD -5.36 days; 95% CI: -5.76, -4.97; < .001), hemostatic effective rate (OR 1.58, 95% CI: 0.80, 3.12, = .184) . In the present meta-analysis, the positive findings suggest UAE has beneficial effects on refractory PPH. UAE significantly reduced blood loss, shortened the operating time, and length of stay compared with hysterectomy. And there is no difference between the UAE group and hysterectomy group in hemostatic effective rate. However, those findings should be treated with caution because of heterogeneity and potential biases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14767058.2018.1497599 | DOI Listing |
Cureus
October 2024
Obstetrics and Gynaecology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND.
Int J Gynaecol Obstet
October 2024
Unit of Obstetrics, Department of Woman, Child and Neonate, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Cureus
September 2024
Intensive Care Unit, Yasodha Hospitals, Secunderabad, IND.
Postpartum hemorrhage (PPH) is one of the leading causes of maternal morbidity and mortality worldwide. The management of severe PPH remains challenging despite advances in obstetric care. Conventional methods of management with uterotonic agents, surgical techniques, and blood transfusions often fail to provide adequate hemostasis, more so in refractory cases.
View Article and Find Full Text PDFDiagnostics (Basel)
September 2024
Department of Obstetrics and Gynecology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Postpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality. Routine treatment of PPH includes uterotonics, tranexamic acid, curettage, uterine (balloon) tamponade, compression sutures, uterine artery ligation, and, if available, transcatheter arterial embolization (TAE). In cases of severe PPH refractory to standard medical and surgical management, hysterectomy is usually the ultima ratio, and is equally associated with a higher rate of complications.
View Article and Find Full Text PDFCureus
July 2024
Pathology, School of Allied Health Sciences, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
When traditional therapies fail to control obstetric emergencies such as postpartum hemorrhage (PPH), uterine artery embolization (UAE) has become an essential intervention. This case study demonstrates the effective use of UAE in a 32-year-old patient who had an elective cesarean section and was experiencing refractory PPH. Despite initial attempts at controlling bleeding with uterotonic agents and surgical intervention, the hemorrhage persisted, necessitating packed red blood cell transfusion.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!